JP5435951B2 - コリナンテ種の樹皮からの抽出物、その使用、およびそれを含有する薬剤、ダイエット食品および医薬品 - Google Patents

コリナンテ種の樹皮からの抽出物、その使用、およびそれを含有する薬剤、ダイエット食品および医薬品 Download PDF

Info

Publication number: JP5435951B2
Authority: JP; Japan
Prior art keywords: extract; corinante; bark; mixture; pain
Prior art date: 2005-11-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP2008539325A

Other languages

English (en)

Japanese (ja)

Other versions

JP2009514916A (ja

Inventor

エゴン・コッホ

ヘルマン・ハウエル

Original Assignee

ドクター．ヴィルマーシュワーベゲーエムベーハーウントツェーオー．カーゲー

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-08

Filing date

2006-11-07

Publication date

2014-03-05

2006-11-07 Application filed by ドクター．ヴィルマーシュワーベゲーエムベーハーウントツェーオー．カーゲー filed Critical ドクター．ヴィルマーシュワーベゲーエムベーハーウントツェーオー．カーゲー

2009-04-09 Publication of JP2009514916A publication Critical patent/JP2009514916A/ja

2014-03-05 Application granted granted Critical

2014-03-05 Publication of JP5435951B2 publication Critical patent/JP5435951B2/ja

Status Expired - Fee Related legal-status Critical Current

2026-11-07 Anticipated expiration legal-status Critical

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Natural Medicines & Medicinal Plants (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Obesity (AREA)
Botany (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Gynecology & Obstetrics (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Medicines Containing Plant Substances (AREA)

JP2008539325A 2005-11-08 2006-11-07 コリナンテ種の樹皮からの抽出物、その使用、およびそれを含有する薬剤、ダイエット食品および医薬品 Expired - Fee Related JP5435951B2 (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102005053241A DE102005053241A1 (de)	2005-11-08	2005-11-08	Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen
DE102005053241.1		2005-11-08
PCT/EP2006/010663 WO2007054269A2 (fr)	2005-11-08	2006-11-07	Extraits d'ecorce de varietes de corynanthe, utilisation de ceux-ci et medicaments, aliments dietetiques et preparations pharmaceutiques contenant ces extraits

Publications (2)

Publication Number	Publication Date
JP2009514916A JP2009514916A (ja)	2009-04-09
JP5435951B2 true JP5435951B2 (ja)	2014-03-05

Family

ID=37982546

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2008539325A Expired - Fee Related JP5435951B2 (ja)	2005-11-08	2006-11-07	コリナンテ種の樹皮からの抽出物、その使用、およびそれを含有する薬剤、ダイエット食品および医薬品

Country Status (12)

Country	Link
US (1)	US20090142428A1 (fr)
EP (1)	EP1945238A2 (fr)
JP (1)	JP5435951B2 (fr)
KR (1)	KR101306599B1 (fr)
CN (1)	CN101291682A (fr)
AU (1)	AU2006312678B2 (fr)
BR (1)	BRPI0618634A2 (fr)
CA (1)	CA2624703A1 (fr)
DE (1)	DE102005053241A1 (fr)
RU (1)	RU2399378C2 (fr)
UA (1)	UA94434C2 (fr)
WO (1)	WO2007054269A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101683337B (zh) *	2008-09-27	2011-12-07	复旦大学	柯楠因在制备治疗心肌损伤性心脏病药物中的用途
JP2011125331A (ja) *	2009-11-17	2011-06-30	Taisho Pharmaceutical Co Ltd	魚鱗粉末含有コーティング錠剤
CN102002039B (zh) *	2010-11-12	2012-05-09	天医堂(厦门)生物工程有限公司	一种从育亨宾树皮中提取育亨宾的方法
CN102030747A (zh) *	2010-11-19	2011-04-27	陕西嘉禾植物化工有限责任公司	一种育亨宾碱的制备方法
EP3646871A1 (fr) *	2018-10-30	2020-05-06	SEROJAC PME Handels GmbH	Traitement et prévention de l'éjaculation précoce (pe)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2112344A1 (en) *	1970-10-27	1972-06-16	Omnium Chimique Sa	Hypotensive, sedative extract of pseudocni - chona africana
BE758049A (fr) *	1970-10-27	1971-04-01	Omnium Chimique Sa	Produit pharmaceutique a proprietes hypotensives et sedatives et son procede d'obtention.
DE3204960A1 (de) *	1982-02-12	1983-08-25	Fa. Dr. Willmar Schwabe, 7500 Karlsruhe	Corynanthein-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US6323211B1 (en) *	1996-02-02	2001-11-27	Nitromed, Inc.	Compositions and methods for treating sexual dysfunctions
FR2765483B1 (fr) *	1997-07-04	2000-02-04	Philippe Gorny	Medicament destine a traiter les dysfonctions erectiles
IT1293539B1 (it) *	1997-07-16	1999-03-01	Sigma Tau Ind Farmaceuti	Composizione nutritiva per soggetti in stato di debilitazione causato da stress
ITMI20011237A1 (it) *	2001-06-12	2002-12-12	Enzo Leone	Uso della yohimbina per la preparazione di farmaci ad attivita' immunobiologica

2005
- 2005-11-08 DE DE102005053241A patent/DE102005053241A1/de not_active Withdrawn
2006
- 2006-11-07 UA UAA200807765A patent/UA94434C2/ru unknown
- 2006-11-07 US US12/084,745 patent/US20090142428A1/en not_active Abandoned
- 2006-11-07 RU RU2008119965/21A patent/RU2399378C2/ru not_active IP Right Cessation
- 2006-11-07 EP EP06818406A patent/EP1945238A2/fr not_active Withdrawn
- 2006-11-07 CN CNA2006800388275A patent/CN101291682A/zh active Pending
- 2006-11-07 AU AU2006312678A patent/AU2006312678B2/en not_active Ceased
- 2006-11-07 WO PCT/EP2006/010663 patent/WO2007054269A2/fr not_active Ceased
- 2006-11-07 BR BRPI0618634-3A patent/BRPI0618634A2/pt not_active IP Right Cessation
- 2006-11-07 JP JP2008539325A patent/JP5435951B2/ja not_active Expired - Fee Related
- 2006-11-07 KR KR1020087013748A patent/KR101306599B1/ko not_active Expired - Fee Related
- 2006-11-07 CA CA002624703A patent/CA2624703A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
KR101306599B1 (ko)	2013-09-10
UA94434C2 (ru)	2011-05-10
DE102005053241A1 (de)	2007-05-16
RU2399378C2 (ru)	2010-09-20
WO2007054269A3 (fr)	2007-08-09
BRPI0618634A2 (pt)	2011-09-06
RU2008119965A (ru)	2009-12-20
AU2006312678B2 (en)	2013-03-28
JP2009514916A (ja)	2009-04-09
AU2006312678A1 (en)	2007-05-18
CN101291682A (zh)	2008-10-22
WO2007054269A2 (fr)	2007-05-18
US20090142428A1 (en)	2009-06-04
KR20080071172A (ko)	2008-08-01
CA2624703A1 (fr)	2007-05-18
EP1945238A2 (fr)	2008-07-23

Publication	Publication Date	Title
US11690812B2 (en)	2023-07-04	Methods and compositions for the treatment of steatosis-associated disorders
US8557302B2 (en)	2013-10-15	Andrographis paniculata extract
CN101977596A (zh)	2011-02-16	大麻素类的新用途
Wang et al.	2022	Kynurenic acid ameliorates lipopolysaccharide-induced endometritis by regulating the GRP35/NF-κB signaling pathway
Ardiana et al.	2018	Antidiabetic activity studies of white tea (Camellia sinensis (L.) O. Kuntze) ethanolic extracts in streptozotocin-nicotinamide induced diabetic rats
KR101241050B1 (ko)	2013-03-11	인삼열매 추출물을 함유하는 남성 성기능 개선용 조성물
JP5435951B2 (ja)	2014-03-05	コリナンテ種の樹皮からの抽出物、その使用、およびそれを含有する薬剤、ダイエット食品および医薬品
RU2727142C2 (ru)	2020-07-21	Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей
KR102191405B1 (ko)	2020-12-16	간 질환 예방 또는 치료용 조성물
JP2003502376A (ja)	2003-01-21	性機能障害および血管収縮に関する疾患の予防および治療におけるイカリンの使用
MX2008005921A (en)	2008-09-02	Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts
CN115397449A (zh)	2022-11-25	香蜂花叶的分步提取物以及包含该提取物的新的药物组合物
KR101698270B1 (ko)	2017-01-19	황금 추출물을 포함하는 항당뇨 및 항비만 효과 증진용 조성물
Jalili et al.	2019	Harmine recover kidney damage induced by morphine in male rats
WO2009149621A1 (fr)	2009-12-17	Utilisation de l’icariside ii dans la fabrication de produits pour prévenir ou traiter un dysfonctionnement sexuel masculin ou féminin
KR20160011572A (ko)	2016-02-01	어성초 추출물을 포함하는 항당뇨 및 항비만 효과 증진용 조성물
KR101832351B1 (ko)	2018-02-27	신코닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학적 조성물
KR101089987B1 (ko)	2011-12-05	옥미수로부터 분리된 플라보노이드계 화합물을 함유하는 비뇨기계 질환 증상 개선용 건강기능식품 및 비뇨기계 질환 치료제
Shuman et al.	2016	Protective effect of melatonin on soluble ABeta1-42-induced memory impairment, astrogliosis, and synaptic dysfunction via the Musashi1/Notch1/Hes1 signaling pathway in the rat hippocampus
CN112274557A (zh)	2021-01-29	冬凌草叶水提物粉末,其制备,抗动脉血栓作用及应用
Elewa	2014	STUDY THE NEPHRO-PROTECTIVE EFFECTS OF LOSARTAN ON RATS

Legal Events

Date	Code	Title	Description
2009-08-13	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090812
2012-06-07	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120606
2012-08-24	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120823
2012-12-06	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121205
2013-02-23	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130222
2013-02-28	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130227
2013-10-10	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131009
2013-11-01	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131031
2013-11-22	TRDD	Decision of grant or rejection written
2013-11-27	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131126
2013-12-19	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131210
2013-12-20	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2016-12-20	LAPS	Cancellation because of no payment of annual fees